United States FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics
The approval marks the first new steroid on the US ophthalmic market in more than 15 years
The “fourth dimension” of home monitoring
A longitudinal, AI-based approach to fluid quantification
Where women stand: A progress report on gender equity in ophthalmology
Mentorship, leadership and addressing bias are key areas for improvement
AI models used to automate remote screening for diabetic retinopathy
The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions
Book excerpt: Rescuing failed penetrating keratoplasty grafts
Penetrating keratoplasty remains a popular choice for certain patients
OCT retinal scans show the eye-kidney connection
The kidney and eye are structurally similar and the diseases of the organs may present via common pathways
Translocated gut bacteria possible cause of some inherited eye diseases
The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye
Prevent Blindness launches ROP Awareness Week with education and support resources
The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March
Promising avenues could simplify glaucoma management – just in time
Innovative therapies scale up to meet needs of a growing patient population
OrthoK lenses: Possible long-term axial length shortening for myopic patients
Patient age is significant in the long-term effect of orthokeratology lenses
Researchers present new monitoring option for intermediate uveitis
Optical coherence tomography angiography could also identify patients at risk of disease progression
Sight Sciences announces European launch of OMNI Surgical System Ergo-Series
The company made its CE Mark announcement during the ESCRS Winter Meeting
Listening to the heart: Lessons from cardiology in remote monitoring and AI
Physicians explore how other specialties adopt and integrate remote monitoring
Beacon Therapeutics shares 12-Month Data from Phase 2 SKYLINE trial of AGTC-501 for patients with XLRP
The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024
US FDA grants OKYO Pharma approval of IND for neuropathic corneal pain therapy OK-101
The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP
Optica releases data on spiral diopter lens developed for multifocal vision correction
The technology has potential for applications in contact lenses and intraocular implants
Iridex Corporation receives European patent on MicroPulse technology
According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields
UCL and Moorfields Eye Hospital receive £5 million toward eye health research facility Oriel
An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027
Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye
Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images
Extracellular vesicles could be the future of retinal diseases
How this treatment paradigm could change ocular cell therapy
Angiogenesis 2024: Highlighting 72-week results from the BALATON and COMINO Phase 3 studies of faricimab in retinal vein occlusion
Ramin Tadayoni, MD, PhD, highlights data from the BALATON and COMINO Phase 3 studies about faricimab
Voyager study provides data on real-world effectiveness of faricimab for nAMD and DME
Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference
Angiogenesis 2024: Targeting Ang2 and VEGF – Biology, Pharmacokinetics and Latest Clinical Data in nAMD and DME
Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design
Angiogenesis 2024: The implication of longitudinal AI-based fluid quantification for at-home monitoring
Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis
Angiogenesis 2024: Findings from the DAVIO 2 trial, assessing EYP-1901 vs aflibercept for wet AMD
Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data
Angiogenesis 2024: Expanded efficacy data from the GATHER 2 trial
Sydney M Crago, editor of Modern Retina, talks with Arshad M Khanani, MD, MA, FASRS, about the expanded efficacy data from the GATHER 2 trial, presented at the 2024 Angiogenesis Symposium
Angiogenesis 2024: Distinguishing aspects of early-onset AMD
EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants
Multimodal assessment of OCT adds perspective on GA and AMD progression
Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging
Kiora Pharmaceuticals and Théa Open Innovation announce partnership, will target IRDs
Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases
Case report: diversifying cataract outcomes
Many options with one single Nd:YAG laser
